A novel nonsense variant associated with Danon disease in a pediatric male: A case report

2021 ◽  
Vol 132 (2) ◽  
pp. S23
Author(s):  
Daniela Castillo-Garcia ◽  
Magdalena Cerón-Rodriguez ◽  
Carlos Patricio Acosta-Rodriguez-Bueno ◽  
Jesús Aguirre-Hernández ◽  
Judith Almanza-Aranda ◽  
...  
Keyword(s):  
2018 ◽  
Vol 08 (03) ◽  
Author(s):  
Olusan AA ◽  
Balachandran KP
Keyword(s):  

2016 ◽  
Vol 25 (5) ◽  
pp. 423-431 ◽  
Author(s):  
Irene Bottillo ◽  
Carla Giordano ◽  
Bruna Cerbelli ◽  
Daniela D'Angelantonio ◽  
Martina Lipari ◽  
...  

2009 ◽  
Vol 32 (S1) ◽  
pp. 115-122 ◽  
Author(s):  
G. Regelsberger ◽  
R. Höftberger ◽  
W. F. Pickl ◽  
G. J. Zlabinger ◽  
U. Körmöczi ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Valeria Novelli ◽  
Antonio Bisignani ◽  
Gemma Pelargonio ◽  
Guido Primiano ◽  
Maria Lucia Narducci ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Zongzhe Li ◽  
Fei Ma ◽  
Rui Li ◽  
Zhichao Xiao ◽  
Hesong Zeng ◽  
...  

Danon disease (DD) is a rare glycogen storage lysosomal disorder caused by mutations in the LAMP2 gene. Patients with DD are usually characterized clinically by severe multisystem syndromes. We describe a specific family with a novel pathogenic splice-altering mutation in the LAMP2 gene (c.741+2T>C) with cardiac-only symptoms (frequent ventricular tachycardia, intraventricular block, and hypertrophic cardiomyopathy). Minigene assays were used to evaluate the consequence of the splice-site mutation in the LAMP2 gene. The results showed that the c.741+2T>C mutation led to extra 6-bp preservation of intron 5 at the junction between exons 5 and 6 during transcriptional processing of the mRNA, which creates a stop codon and truncated the LAMP2 protein to 248-amino-acid residues. The mutant LAMP2 protein was predicted to have a conformational change, lacks the important transmembrane domain, and subsequent protein destabilization.


Medicine ◽  
2020 ◽  
Vol 99 (40) ◽  
pp. e22640
Author(s):  
Ying Zhang ◽  
Hang Ren ◽  
Shanshan Zhou

2007 ◽  
Vol 135 (3-4) ◽  
pp. 197-200
Author(s):  
Suad Catovic ◽  
Petar Otasevic

Danon disease, a rare glycogen storage disease, is a dominant X-linked disorder. It is due to mutation in gene for lysosome-associated membrane protein 2 (LAMP 2). The LAMP 2 gene is located on Xq24, and its mutation causes primary deficiency of LAMP 2 and myocyte hypertrophy by accumulations of vacuoles containing glycogen. Danon disease is clinically characterized by the triad of hypertrophic cardiomyopathy (HCM), proximal myopathy and mental retardation. Myopathy and mental retardation can be absent, and cardiomyopathy is usually hypertrophic. This is a case report of the patient with genetically confirmed Danon disease and mixed cardiomyopathy, but without myopathy and mental retardation. ECG showed typical Wolff-Parkinson-White (WPW) pattern while echocardiography demonstrated hypertrophy and dilatation of all cardiac chambers with impaired systolic and diastolic function. Male sex, early onset of symptoms, massive hypertrophy of the myocardium and ventricular preexcitation indicate a genetic basis for HCM. Therapeutic measures, except heart transplantation, do not improve prognosis substantially. Only an accurate diagnosis in patients with unexplained HCM helps in establishing of the appropriate treatment strategies and adequate genetic consultation. .


2020 ◽  
Vol 29 (4) ◽  
pp. 685-690
Author(s):  
C. S. Vanaja ◽  
Miriam Soni Abigail

Purpose Misophonia is a sound tolerance disorder condition in certain sounds that trigger intense emotional or physiological responses. While some persons may experience misophonia, a few patients suffer from misophonia. However, there is a dearth of literature on audiological assessment and management of persons with misophonia. The purpose of this report is to discuss the assessment of misophonia and highlight the management option that helped a patient with misophonia. Method A case study of a 26-year-old woman with the complaint of decreased tolerance to specific sounds affecting quality of life is reported. Audiological assessment differentiated misophonia from hyperacusis. Management included retraining counseling as well as desensitization and habituation therapy based on the principles described by P. J. Jastreboff and Jastreboff (2014). A misophonia questionnaire was administered at regular intervals to monitor the effectiveness of therapy. Results A detailed case history and audiological evaluations including pure-tone audiogram and Johnson Hyperacusis Index revealed the presence of misophonia. The patient benefitted from intervention, and the scores of the misophonia questionnaire indicated a decrease in the severity of the problem. Conclusions It is important to differentially diagnose misophonia and hyperacusis in persons with sound tolerance disorders. Retraining counseling as well as desensitization and habituation therapy can help patients who suffer from misophonia.


Sign in / Sign up

Export Citation Format

Share Document